Skip To Main Content
Liying Xue on Muck Rack

Liying Xue

As seen in: PLOS ONE, Frontiers, MDPI, JACC (Journal of the American College of Cardiology)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Liying

Contact Liying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy and safety of CD38-directed CAR-T cell therapy for multiple myeloma: a systematic review and meta-analysis

|
By Xinlong Xu, Chang Dong, Jiashuo Guo, Xiaolin Chang, Yu ZHANG, Shuting Gou, Liying Xue, Jie Li
| Frontiers
Abstract Background: Relapsed/refractory multiple myeloma (RRMM) remains a clinical challenge despite therapeutic advances. CD38-directed chimeric antigen receptor T-cell (CAR-T) therapy, especially dual-target CD38/BCMA constructs, represents an emerging immunotherapeutic strategy. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of CD38-directed CAR-T in RRMM. Methods: We systematically searched Medline, Embase, and Cochrane Library up to October 1, 2025.
Open in Who Shared Issue with article?

Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial:

|
By Liying Xue, Mesbah Uddin, Niekbachsh Mohammadnia, Lucas T.W. Vestjens
| JACC (Journal of the American College of Cardiology)
JACC Journals › JACC › Archives › Just Accepted Research Article : JACC Preprint Formats available You can view the full content in the following formats: Information & Authors Published In History Received: 24 July 2025 Revised: 11 August 2025 Accepted: 12 August 2025 Published online: 29 August 2025 Metrics & Citations How to cite this article: Mohammadnia, N, Xue, L, Vestjens, L. et al. Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial.
Open in Who Shared Issue with article?

Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women:

|
By Mesbah Uddin, Liying Xue, Yash Pershad, Daniel Ezzat
| JACC (Journal of the American College of Cardiology)
Cardiovascular disease (CVD) remains a pressing global health challenge, with coronary heart disease (CHD) representing the leading cause of morbidity and mortality.1-3 Despite significant advancements in the clinical management of CHD, preventive strategies targeting modifiable risk factors to slow disease progression remain suboptimal.2-5 One emerging and increasingly recognized CVD risk factor is clonal hematopoiesis of indeterminate potential (CHIP), which is characterized by the...
Open in Who Shared Issue with article?
See all 6 licensed articles (7 Total)